Revisiting the JOQUER trial: stratification of primary Sjögren’s syndrome and the clinical and interferon response to hydroxychloroquine

類似資料

• Hydroxychloroquine treatment downregulates systemic interferon activation in primary Sjögren’s syndrome in the JOQUER randomized trial
  著者:: Bodewes, Iris L A, 等
  出版事項: (2020)
• Characteristics of Sjögren’s syndrome associated with rheumatoid arthritis
  著者:: Xavier Mariette, 等
  出版事項: (2022-02-01)
• Comorbidities in the UK Primary Sjögren’s Syndrome Registry
  著者:: Jessica Tarn, 等
  出版事項: (2022-04-01)
• EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome
  著者:: Seror, Raphaèle, 等
  出版事項: (2010)
• Fatigue in primary Sjögren’s syndrome (pSS) is associated with lower levels of proinflammatory cytokines: a validation study
  著者:: Davies, Kristen, 等
  出版事項: (2019)